Avoidance of st-segment-elevation myocardial infarction treatment for >1 week due to covid-19 fears

Rahul V. Annabathula, Gregory J. Sinner, Talal S. Alnabelsi, Rachel P. Goodwin, Vincent L. Sorrell

Research output: Contribution to journalArticlepeer-review


During the coronavirus disease 2019 (COVID-19) pandemic, social distancing guidelines have negatively affected the care-seeking behavior of patients with chronic medical condi-tions, including those with cardiovascular disease. We report the case of a 60-year-old man with vague gastrointestinal symptoms who waited more than 1 week to seek treatment for fear of COVID-19 infection. On presentation at another hospital, he was found to have had an anterior myocardial infarction, and he underwent percutaneous coronary intervention to stent an occluded proximal left anterior descending coronary artery. Sub-sequently, the patient experienced refractory cardiogenic shock and, during his transfer to our hospital, refractory ventricular tachycardia, which ultimately proved fatal. (Tex Heart Inst J 2021;48(4):e207390).

Original languageEnglish
Article numbere207390
JournalTexas Heart Institute Journal
Issue number4
StatePublished - 2021

Bibliographical note

Publisher Copyright:
© 2021 by the Texas Heart® Institute, Houston.


  • COVID-19
  • Physical distancing
  • ST elevation myocardial infarction/ complications
  • Time-to-treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Avoidance of st-segment-elevation myocardial infarction treatment for >1 week due to covid-19 fears'. Together they form a unique fingerprint.

Cite this